CAS No 14698-29-4 , 5-ethyl-8-oxo-[1,3]dioxolo[4,5-g]quinoline-7-carboxylic acid Search by region : India

Name: 5-ethyl-8-oxo-[1,3]dioxolo[4,5-g]quinoline-7-carboxylic acid
Synonyms: Dioxacin; Nidantin; Gramurin; Oksaren;Emyrenil; Oxolinic; Utibid;5-ethyl-8-oxo-[1,3]dioxolo[4,5-g]quinoline-7-carboxylic acid; 14698-29-4; Prodoxol;
CAS Registry Number:14698-29-4
Transport: 25kgs
Density: 1.483 g/cm³
Refractive index: 1.638
Water Solubility: Insoluble
Safety Statements: R22
Hazard Symbols: Xn: Harmful;
EINECS: 238-750-8
Molecular Weight: 261.23014
InchiKey: KYGZCKSPAKDVKC-UHFFFAOYSA-N
InChI: InChI=1S/C13H11NO5/c1-2-14-5-8(13(16)17)12(15)7-3-10-11(4-9(7)14)19-6-
18-10/h3-5H,2,6H2,1H3,(H,16,17)
Risk Statements: S22;S24/25
Molecular Formula: C₁₃H₁₁NO₅
Molecular Structure:

Related products

Select to

14698-29-4 Oxolinic Acid

Triveni Chemicals null
Tel: +91-(260)-2400022, 3258683
Fax: +91-(260)-2400022/3264008
Address: 135, Pancharatna, Char Rasta, G.I.D.C., Vapi, Gujarat 396 195, null,nullIndia

14698-29-4 OXOLINIC ACID

JAI RADHE SALES null
Fax: 0091-79-26569884
Address: 309/310 HARIKRUPA TOWER,NR.OLD SHARDA MANDIR CHAR RASTA,ELLISBRIDGE ,AHMEDABAD,GUJRAT , INDIA. null,nullIndia

Select to

1/1

References of 5-ethyl-8-oxo-[1,3]dioxolo[4,5-g]quinoline-7-carboxylic acid

Title: Oxolinic Acid
CAS Registry Number: 14698-29-4
CAS Name: 5-Ethyl-5,8-dihydro-8-oxo-1,3-dioxolo[4,5-g]quinoline-7-carboxylic acid
Synonyms: 1-ethyl-1,4-dihydro-6,7-methylenedioxy-4-oxo-3-quinolinecarboxylic acid; 1-ethyl-6,7-methylenedioxy-4-quinolone-3-carboxylic acid
Manufacturers' Codes: W-4565
Trademarks: Inoxyl (Debat); Nidantin (Warner-Lambert); Uritrate (Warner-Lambert); Urotrate (Warner-Lambert)
Molecular Formula: C13H11NO5
Molecular Weight: 261.23
Percent Composition: C 59.77%, H 4.24%, N 5.36%, O 30.62%
Literature References: Quinolone antibacterial. Prepn: Kaminsky, Meltzer, US 3287458 (1966 to Warner-Lambert); eidem, J. Med. Chem. 11, 160 (1968). Pharmacology: Turner et al., Antimicrob. Agents Chemother. 1967, 475 sqq. Metabolism studies: DiCarlo et al., Arch. Biochem. Biophys. 127, 503 (1968); Crew et al., Xenobiotica 1, 193 (1971). Use in urinary tract infections: S. Kalowski et al., Med. J. Aust. 21, 345 (1979); E. Anza et al., Minerva Med. 70, 2333 (1979). Mechanism of action study: H. T. Wright et al., Science 213, 455 (1981). Brief review of therapeutic use: R. Glickman et al., Am. J. Hosp. Pharm. 36, 1077-1079 (1979).
Properties: Crystals from DMF, mp 314-316° (dec). LD50 in mice, rats (mg/kg): >6000, >2000 orally (Turner).
Melting point: mp 314-316° (dec)
Toxicity data: LD50 in mice, rats (mg/kg): >6000, >2000 orally (Turner)
Therap-Cat: Antibacterial.
Therap-Cat-Vet: Antibacterial.
Keywords: Antibacterial (Synthetic); Quinolones and Analogs.